Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation

被引：5

作者：

Peeters, Janneke G. C. ^{[1
]}

Silveria, Stephanie ^{[1
]}

Ozdemir, Merve ^{[1
]}

Ramachandran, Srinivas ^{[2
,3
]}

DuPage, Michel ^{[1
]}

机构：

[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Mol Med, Berkeley, CA 94720 USA

[2] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA

[3] Univ Colorado, Sch Med, RNA Biosci Initiat, Aurora, CO 80045 USA

来源：

CELL REPORTS | 2024年 / 43卷 / 09期

基金：

美国国家卫生研究院;

关键词：

TRANSCRIPTION FACTOR FOXP3; POLYCOMB-GROUP; DEVELOPMENTAL REGULATORS; LIMITS INFLAMMATION; CUTTING EDGE; EXPRESSION; CD103; GENE; PHENOTYPE; MUTATIONS;

D O I：

10.1016/j.celrep.2024.114724

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The immunosuppressive function of regulatory T (Treg) cells is essential for maintaining immune homeostasis. Enhancer of zeste homolog 2 (EZH2), a histone H3 lysine 27 (H3K27) methyltransferase, plays a key role in maintaining Treg cell function upon CD28 co-stimulation, and Ezh2 deletion in Treg cells causes autoimmunity. Here, we assess whether increasing H3K27me3 levels, by using an Ezh2(Y641F) gain-of-function mutation, will improve Treg cell function. We find that Treg cells expressing Ezh2(Y641F) display an effector Treg phenotype, are poised for improved homing to organ tissues, and can accelerate remission from autoimmunity. The H3K27me3 landscape and transcriptome of naive Ezh2(Y641F) Treg cells exhibit a redistribution of H3K27me3 modifications that recapitulates the gene expression profile of activated Ezh2(WT) Treg cells after CD28 co- stimulation. Altogether, increased H3K27me3 levels promote the differentiation of effector Treg cells that can better suppress autoimmunity.

引用

页数：26

共 117 条

[1]

Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745

[2] CD103 is a hallmark of tumor-infiltrating regulatory T cells [J].

Anz, David ;

Mueller, Wolfgang ;

Golic, Michaela ;

Kunz, Wolfgang G. ;

Rapp, Moritz ;

Koelzer, Viktor H. ;

Ellermeier, Jonathan ;

Ellwart, Joachim W. ;

Schnurr, Max ;

Bourquin, Carole ;

Endres, Stefan .

INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (10) :2417-2426

[3] A Distinct Function of Regulatory T Cells in Tissue Protection [J].

Arpaia, Nicholas ;

Green, Jesse A. ;

Moltedo, Bruno ;

Arvey, Aaron ;

Hemmers, Saskia ;

Yuan, Shaopeng ;

Treuting, Piper M. ;

Rudensky, Alexander Y. .

CELL, 2015, 162 (05) :1078-1089

[4] Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells [J].

Arvey, Aaron ;

van der Veeken, Joris ;

Samstein, Robert M. ;

Feng, Yongqiang ;

Stamatoyannopoulos, John A. ;

Rudensky, Alexander Y. .

NATURE IMMUNOLOGY, 2014, 15 (06) :580-587

[5] CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+T cell antitumor immunity [J].

Ayala, Mariela A. Moreno ;

Campbell, Timothy F. ;

Zhang, Chenyu ;

Dahan, Noa ;

Bockman, Alissa ;

Prakash, Varsha ;

Feng, Lawrence ;

Sher, Theo ;

DuPage, Michel .

IMMUNITY, 2023, 56 (07) :1613-+

[6] Treg programming and therapeutic reprogramming in cancer [J].

Ayala, Mariela A. Moreno ;

Li, Zehui ;

DuPage, Michel .

IMMUNOLOGY, 2019, 157 (03) :198-209

[7] Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response [J].

Beguelin, Wendy ;

Teater, Matt ;

Meydan, Cem ;

Hoehn, Kenneth B. ;

Phillip, Jude M. ;

Soshnev, Alexey A. ;

Venturutti, Leandro ;

Rivas, Martin A. ;

Calvo-Fernandez, Maria T. ;

Gutierrez, Johana ;

Camarillo, Jeannie M. ;

Takata, Katsuyoshi ;

Tarte, Karin ;

Kelleher, Neil L. ;

Steidl, Christian ;

Mason, Christopher E. ;

Elemento, Olivier ;

Allis, C. David ;

Kleinstein, Steven H. ;

Melnick, Ari M. .

CANCER CELL, 2020, 37 (05) :655-+

[8] EZH2 and BCL6 Cooperate to Assemble CBX8-BCOR Complex to Repress Bivalent Promoters, Mediate Germinal Center Formation and Lymphomagenesis [J].

Beguelin, Wendy ;

Teater, Matt ;

Gearhart, Micah D. ;

Fernandez, Maria Teresa Calvo ;

Goldstein, Rebecca L. ;

Cardenas, Mariano G. ;

Hatzi, Katerina ;

Rosen, Monica ;

Shen, Hao ;

Corcoran, Connie M. ;

Hamline, Michelle Y. ;

Gascoyne, Randy D. ;

Levine, Ross L. ;

Abdel-Wahab, Omar ;

Licht, Jonathan D. ;

Shaknovich, Rita ;

Elemento, Olivier ;

Bardwell, Vivian J. ;

Melnick, Ari M. .

CANCER CELL, 2016, 30 (02) :197-213

[9] EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation [J].

Beguelin, Wendy ;

Popovic, Relja ;

Teater, Matt ;

Jiang, Yanwen ;

Bunting, Karen L. ;

Rosen, Monica ;

Shen, Hao ;

Yang, Shao Ning ;

Wang, Ling ;

Ezponda, Teresa ;

Martinez-Garcia, Eva ;

Zhang, Haikuo ;

Zheng, Yupeng ;

Verma, Sharad K. ;

McCabe, Michael T. ;

Ott, Heidi M. ;

Van Aller, Glenn S. ;

Kruger, Ryan G. ;

Liu, Yan ;

McHugh, Charles F. ;

Scott, David W. ;

Chung, Young Rock ;

Kelleher, Neil ;

Shaknovich, Rita ;

Creasy, Caretha L. ;

Gascoyne, Randy D. ;

Wong, Kwok-Kin ;

Cerchietti, Leandro ;

Levine, Ross L. ;

Abdel-Wahab, Omar ;

Licht, Jonathan D. ;

Elemento, Olivier ;

Melnick, Ari M. .

CANCER CELL, 2013, 23 (05) :677-692

[10] The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 [J].

Bennett, CL ;

Christie, J ;

Ramsdell, F ;

Brunkow, ME ;

Ferguson, PJ ;

Whitesell, L ;

Kelly, TE ;

Saulsbury, FT ;

Chance, PF ;

Ochs, HD .

NATURE GENETICS, 2001, 27 (01) :20-21

← 1 2 3 4 5 6 7 8 9 10 →